HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Helge Martens Selected Research
Helge Martens Research Topics
Disease
2
Carcinogenesis
01/2021 - 12/2017
2
Neoplasms (Cancer)
01/2021 - 12/2017
2
Glioma (Gliomas)
01/2021 - 12/2017
2
Brain Ischemia (Cerebral Ischemia)
07/2005 - 05/2002
2
Ischemia
07/2005 - 05/2002
1
Spinal Muscular Atrophy (Progressive Muscular Atrophy)
12/2021
1
Oligodendroglioma
01/2021
1
Brain Neoplasms (Brain Tumor)
01/2021
1
Inflammation (Inflammations)
12/2017
1
Carcinoma (Carcinomatosis)
12/2017
1
Shellfish Poisoning
05/2017
1
Cakut
01/2017
1
Infarction (Infarctions)
07/2005
1
Wounds and Injuries (Trauma)
07/2005
1
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2002
Drug/Important Bio-Agent (IBA)
1
Oxidoreductases (Dehydrogenase)
IBA
12/2021
1
Transketolase
IBA
12/2021
1
DNA (Deoxyribonucleic Acid)
IBA
01/2021
1
Cadherins (E-Cadherin)
IBA
01/2021
1
Catenins
IBA
01/2021
1
Janus Kinase Inhibitors
IBA
12/2017
1
ruxolitinib
IBA
12/2017
1
Interferon Type I
IBA
12/2017
1
Saxitoxin
IBA
05/2017
1
gonyautoxins
IBA
05/2017
1
OSM-LIF Receptors
IBA
01/2017
1
Messenger RNA (mRNA)
IBA
01/2017
1
Calpain
IBA
07/2005
1
A-558693
IBA
07/2005
1
mu-calpain
IBA
07/2005
1
Peptide Hydrolases (Proteases)
FDA Link
07/2005
1
calpain inhibitors
IBA
07/2005
1
Collagen Type IV (Type IV Collagen)
IBA
05/2002
1
Proteins (Proteins, Gene)
FDA Link
05/2002
1
salicylhydroxamic acid (SHAM)
IBA
05/2002
Therapy/Procedure
2
Sutures (Suture)
07/2005 - 05/2002
1
Kidney Transplantation
01/2017